journal article·2024-10-07

mRNA-Based Cancer Vaccines: Advancements and Prospects

Lijin Wu, Weicheng Yi, Shiyu Yao, Sitao Xie, Ruizi Peng, Jing Zhang, Weihong Tan

Publisher page

Abstract

The success of mRNA COVID-19 vaccines has reinvigorated research and interest in mRNA-based cancer vaccines. Despite promising results in clinical trials, therapeutic mRNA-based cancer vaccines have not yet been approved for human use. These vaccines are designed to trigger tumor regression, establish enduring antitumor memory, and mitigate adverse reactions. However, challenges such as tumor-induced immunosuppression and immunoresistance significantly hinder their application. Here, we provide an overview of the recent advances of neoantigen discovery and delivery systems for mRNA vaccines, focusing on improving clinical efficacy. Additionally, we summarize the recent clinical advances involving mRNA cancer vaccines and discuss prospective strategies for overcoming immuneresistance.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Immunotherapy and Immune Responses · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Key Laboratory of Zhejiang Province for Aptamers and Theranostics, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China

School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China

University of Chinese Academy of Sciences, No.19 A Yuquan Road, Beijing 100049, China

Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan 410082, China

Funding

Science and Technology Department of Zhejiang Province · National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1038/s41586-023-06243-w10.1038/s41586-023-06243-w ↗
2. 10.1038/s41568-021-00346-010.1038/s41568-021-00346-0 ↗
3. 10.1038/d41591-023-00072-010.1038/d41591-023-00072-0 ↗
4. 10.1038/nrd427810.1038/nrd4278 ↗
5. 10.1038/s41568-019-0162-410.1038/s41568-019-0162-4 ↗
6. 10.1093/annonc/mdx68710.1093/annonc/mdx687 ↗
7. 10.1038/s41392-022-01270-x10.1038/s41392-022-01270-x ↗
8. 10.1038/s41576-019-0180-910.1038/s41576-019-0180-9 ↗
9. 10.1038/s41591-019-0434-210.1038/s41591-019-0434-2 ↗
10. 10.1038/nrc209110.1038/nrc2091 ↗
11. 10.1016/j.isci.2019.10.02810.1016/j.isci.2019.10.028 ↗
12. 10.1016/j.ccell.2018.07.00110.1016/j.ccell.2018.07.001 ↗
13. 10.1038/nbt.423910.1038/nbt.4239 ↗
14. 10.1056/NEJMoa110328310.1056/NEJMoa1103283 ↗
15. 10.1038/nature1049610.1038/nature10496 ↗
16. 10.1016/j.cell.2021.05.03810.1016/j.cell.2021.05.038 ↗
17. 10.1126/scitranslmed.ade288610.1126/scitranslmed.ade2886 ↗
18. 10.3389/fimmu.2017.0180710.3389/fimmu.2017.01807 ↗
19. 10.1158/2326-6066.CIR-16-028010.1158/2326-6066.CIR-16-0280 ↗
20. 10.1038/s41467-023-39425-110.1038/s41467-023-39425-1 ↗
21. 10.1073/pnas.243222010010.1073/pnas.2432220100 ↗
22. 10.1038/ni.166010.1038/ni.1660 ↗
23. 10.1126/science.109552210.1126/science.1095522 ↗
24. 10.1126/science.aaf438410.1126/science.aaf4384 ↗
25. 10.1038/srep2403210.1038/srep24032 ↗
26. 10.1158/2326-6066.CIR-19-005610.1158/2326-6066.CIR-19-0056 ↗
27. 10.1084/jem.2018057710.1084/jem.20180577 ↗
28. 10.1172/JCI8367110.1172/JCI83671 ↗
29. 10.1016/j.molmed.2019.08.00110.1016/j.molmed.2019.08.001 ↗
30. 10.1093/nar/gkaa37910.1093/nar/gkaa379 ↗
31. 10.1038/s41586-019-1671-810.1038/s41586-019-1671-8 ↗
32. 10.1093/nar/gkx76010.1093/nar/gkx760 ↗
33. 10.1016/j.cell.2009.01.01910.1016/j.cell.2009.01.019 ↗
34. 10.1016/j.immuni.2021.11.00110.1016/j.immuni.2021.11.001 ↗
35. 10.1016/j.jconrel.2022.12.03910.1016/j.jconrel.2022.12.039 ↗
36. 10.1016/S1470-2045(22)00372-210.1016/S1470-2045(22)00372-2 ↗
37. 10.1038/nbt.329810.1038/nbt.3298 ↗
38. 10.1039/D1BM00866H10.1039/D1BM00866H ↗
39. 10.1038/s41587-019-0247-310.1038/s41587-019-0247-3 ↗
40. 10.1073/pnas.220784111910.1073/pnas.2207841119 ↗
41. 10.1073/pnas.231127612010.1073/pnas.2311276120 ↗
42. 10.1002/adfm.20220469210.1002/adfm.202204692 ↗
43. 10.1002/adma.20220962410.1002/adma.202209624 ↗
44. 10.1038/s41586-023-06063-y10.1038/s41586-023-06063-y ↗
45. 10.1038/nature1830010.1038/nature18300 ↗
46. 10.1007/82_2020_21710.1007/82_2020_217 ↗
47. 10.1016/j.biomaterials.2021.12130310.1016/j.biomaterials.2021.121303 ↗
48. 10.1038/s41586-020-2537-910.1038/s41586-020-2537-9 ↗
49. 10.1038/nature2300310.1038/nature23003 ↗
50. 10.1200/JCO.2019.3710.1200/JCO.2019.37 ↗